Qbtech develops clinically researched software and objective ADHD tests used in diagnosis, monitoring and treatment. Our products, including QbCheck (flexible at-home and in-clinic testing) and QbTest (in-clinic testing), combine objective data with clinical expertise to improve diagnostic accuracy and patient outcomes.

Our medical technology has been peer-reviewed in over 40 clinical studies, is supported by more than 20 years of research, and is used by thousands of clinicians worldwide. Qbtech's solutions have been recommended by the UK National Institute for Health and Care Excellence (NICE) for assessing ADHD.

We exist to transform ADHD care by reducing diagnostic delays, lowering under- and over-diagnosis, and minimising age and gender bias. The company was founded from personal experience of the diagnostic process and, since 2000, has followed a technology-first approach to combine subjective and objective data in clinical practice.

We work with healthcare providers across multiple sectors to implement objective ADHD testing and clinical support:

For clinicians and organisations seeking implementation or support, Qbtech offers clinical guidance, research resources, and a sales/contact team to help integrate their solutions into care pathways.